189 related articles for article (PubMed ID: 22305281)
1. [Adherence of local (and general) treatments in psoriasis].
Cribier B
Ann Dermatol Venereol; 2012 Jan; 139 Suppl 1():S13-7. PubMed ID: 22305281
[TBL] [Abstract][Full Text] [Related]
2. Objective assessment of compliance with psoriasis treatment.
Zaghloul SS; Goodfield MJ
Arch Dermatol; 2004 Apr; 140(4):408-14. PubMed ID: 15096368
[TBL] [Abstract][Full Text] [Related]
3. [Non adherence and topical steroids].
Aubert H; Barbarot S
Ann Dermatol Venereol; 2012 Jan; 139 Suppl 1():S7-12. PubMed ID: 22305285
[TBL] [Abstract][Full Text] [Related]
4. [The role of dermatologist in adherence to treatment].
Misery L
Ann Dermatol Venereol; 2012 Jan; 139 Suppl 1():S18-21. PubMed ID: 22305282
[TBL] [Abstract][Full Text] [Related]
5. The right dose in the right place: an overview of current prescription, instruction and application modalities for topical psoriasis treatments.
Savary J; Ortonne JP; Aractingi S
J Eur Acad Dermatol Venereol; 2005 Nov; 19 Suppl 3():14-7. PubMed ID: 16274407
[TBL] [Abstract][Full Text] [Related]
6. What's new in the management of psoriasis?
Kinney MA; Feldman SR
G Ital Dermatol Venereol; 2009 Apr; 144(2):103-17. PubMed ID: 19357619
[TBL] [Abstract][Full Text] [Related]
7. [Adherence: definitions and measurement methods: characteristics of adherence to topical treatments].
Halioua B
Ann Dermatol Venereol; 2012 Jan; 139 Suppl 1():S1-6. PubMed ID: 22305280
[TBL] [Abstract][Full Text] [Related]
8. Adherence with topical treatment is poor compared with adherence with oral agents: implications for effective clinical use of topical agents.
Krejci-Manwaring J; McCarty MA; Camacho F; Carroll CL; Johnson K; Manuel J; Balkrishnan R; Hartle J; Fleischer A; Feldman SR
J Am Acad Dermatol; 2006 May; 54(5 Suppl):S235-6. PubMed ID: 16631951
[No Abstract] [Full Text] [Related]
9. Non-adherence and measures to improve adherence in the topical treatment of psoriasis.
Zschocke I; Mrowietz U; Karakasili E; Reich K
J Eur Acad Dermatol Venereol; 2014 May; 28 Suppl 2():4-9. PubMed ID: 24684738
[TBL] [Abstract][Full Text] [Related]
10. Creation of a tool to assess adherence to treatments for acne.
Pawin H; Beylot C; Chivot M; Faure M; Poli F; Revuz J; Dréno B
Dermatology; 2009; 218(1):26-32. PubMed ID: 18946201
[TBL] [Abstract][Full Text] [Related]
11. Adherence to topical therapy decreases during the course of an 8-week psoriasis clinical trial: commonly used methods of measuring adherence to topical therapy overestimate actual use.
Carroll CL; Feldman SR; Camacho FT; Manuel JC; Balkrishnan R
J Am Acad Dermatol; 2004 Aug; 51(2):212-6. PubMed ID: 15280839
[TBL] [Abstract][Full Text] [Related]
12. Adherence to topical treatment in psoriasis: a systematic literature review.
Devaux S; Castela A; Archier E; Gallini A; Joly P; Misery L; Aractingi S; Aubin F; Bachelez H; Cribier B; Jullien D; Le Maître M; Richard MA; Ortonne JP; Paul C
J Eur Acad Dermatol Venereol; 2012 May; 26 Suppl 3():61-7. PubMed ID: 22512682
[TBL] [Abstract][Full Text] [Related]
13. Are we giving patients enough information on how to use topical treatments? Analysis of 767 prescriptions in psoriasis.
Pouplard C; Gourraud PA; Meyer N; Livideanu CB; Lahfa M; Mazereeuw-Hautier J; Le Jeunne P; Sabatini AL; Paul C
Br J Dermatol; 2011 Dec; 165(6):1332-6. PubMed ID: 21711325
[TBL] [Abstract][Full Text] [Related]
14. Topical psoriasis therapy.
Federman DG; Froelich CW; Kirsner RS
Am Fam Physician; 1999 Feb; 59(4):957-62, 964. PubMed ID: 10068717
[TBL] [Abstract][Full Text] [Related]
15. Topical corticosteroid phobia in atopic dermatitis: a study of its nature, origins and frequency.
Aubert-Wastiaux H; Moret L; Le Rhun A; Fontenoy AM; Nguyen JM; Leux C; Misery L; Young P; Chastaing M; Danou N; Lombrail P; Boralevi F; Lacour JP; Mazereeuw-Hautier J; Stalder JF; Barbarot S
Br J Dermatol; 2011 Oct; 165(4):808-14. PubMed ID: 21671892
[TBL] [Abstract][Full Text] [Related]
16. New treatment options for psoriasis.
McClelland PB
Dermatol Nurs; 1997 Oct; 9(5):295-304; quiz 305-6. PubMed ID: 9392761
[TBL] [Abstract][Full Text] [Related]
17. Are ointments better than other vehicles for corticosteroid treatment of psoriasis?
Zivkovich AH; Feldman SR
J Drugs Dermatol; 2009 Jun; 8(6):570-2. PubMed ID: 19537382
[TBL] [Abstract][Full Text] [Related]
18. Approaching psoriasis differently: patient-physician relationships, patient education and choosing the right topical vehicle.
Feldman SR
J Drugs Dermatol; 2010 Aug; 9(8):908-11. PubMed ID: 20684140
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of the two-compound formulation calcipotriol and betamethasone dipropionate compared with commonly used topical treatments in the management of moderately severe plaque psoriasis in Scotland.
Bottomley JM; Auland ME; Morais J; Boyd G; Douglas WS
Curr Med Res Opin; 2007 Aug; 23(8):1887-901. PubMed ID: 17610804
[TBL] [Abstract][Full Text] [Related]
20. Treatment adherence: a hurdle for real-life effectiveness in psoriasis?
Reich K; Daudén E
J Eur Acad Dermatol Venereol; 2014 May; 28 Suppl 2():1-3. PubMed ID: 24684737
[No Abstract] [Full Text] [Related]
[Next] [New Search]
